2021
DOI: 10.25259/sni_416_2021
|View full text |Cite
|
Sign up to set email alerts
|

S-100-negative, GNA11 mutation-positive intramedullary meningeal melanocytoma of the thoracic spine: A radiographic challenge and histologic anomaly

Abstract: Background: Intramedullary melanocytomas are exceedingly rare and their management is largely based on case reports and small clinical series. They have characteristic imaging and histologic findings that can aid in their diagnosis. Genetic testing may be required for definitive diagnosis and management guidance in ambiguous cases. Case Description: We present the case of a thoracic intramedullary meningeal melanocytoma in a patient unable to undergo an MRI. Conclusion: This is the first reported S-100-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
0
0
0
Order By: Relevance
“…This, in conjunction with the invasiveness, highlights its locally aggressive behavior despite its benign biology. This may reinforce the notion that less aggressive surgery should be attempted when removing these tumors, with the aim of obtaining the maximal safe resection, as in the case of Flores et al [18]. This is especially important when considering the advancements in targeted therapies, which may prove effective in treating tumor relapse.…”
Section: Discussionmentioning
confidence: 56%
See 2 more Smart Citations
“…This, in conjunction with the invasiveness, highlights its locally aggressive behavior despite its benign biology. This may reinforce the notion that less aggressive surgery should be attempted when removing these tumors, with the aim of obtaining the maximal safe resection, as in the case of Flores et al [18]. This is especially important when considering the advancements in targeted therapies, which may prove effective in treating tumor relapse.…”
Section: Discussionmentioning
confidence: 56%
“…Similarly, Wagner et al described tumor control at eighteen months with fractionated RT administered for a relapse following GTR [13]. However, in the other seven reports, a relapse after GTR was noted during FU MRI, and adjuvant RT was deemed unnecessary [15,[17][18][19]21]. In the cases described by Horn et al [19], despite GTR, recurrence was noted.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation